Brain Sciences | Free Full-Text | Chaperonology: The Third Eye on Brain Gliomas | HTML
ATRX Alteration Contributes to Tumor Growth and Immune Escape in Pleomorphic Sarcomas
Current biomarker-associated procedures of cancer modeling-a reference in the context of IDH1 mutant glioma | Cell Death & Disease
Cancers | Free Full-Text | The Multiple Facets of ATRX Protein | HTML
Neuroendocrine neoplasms: current and potential diagnostic, predictive and prognostic markers in: Endocrine-Related Cancer Volume 26 Issue 3 (2019)
PDF) IDH mutation, 1p19q codeletion and ATRX loss in WHO grade II gliomas
Topographic mapping of the glioblastoma proteome reveals a triple-axis model of intra-tumoral heterogeneity | Nature Communications
ATRX alteration contributes to tumor growth and immune escape in pleomorphic sarcomas | bioRxiv
CLINICAL RELEVANCE OF MOLECULAR MARKERS IN GLIOMAS - ScienceDirect
Frontiers | Molecular Signatures and Their Clinical Utility in Pancreatic Neuroendocrine Tumors
Diffuse Astrocytoma and Oligodendroglioma: An Integrated Diagnosis and Management | IntechOpen
Cancers | Free Full-Text | ATRX Alteration Contributes to Tumor Growth and Immune Escape in Pleomorphic Sarcomas | HTML
Loss of the chromatin remodeler, ATRX, promotes aggressive features of osteosarcoma with increased NF-κB signaling and integrin receptor binding | bioRxiv
Cancers | Free Full-Text | The Multiple Facets of ATRX Protein | HTML
View of Molecular Markers of Gliomas to Predict Treatment and Prognosis: Current State and Future Directions | Exon Publications
ATRX alteration contributes to tumor growth and immune escape in pleomorphic sarcomas | bioRxiv
Cancers | Free Full-Text | ATRX Alteration Contributes to Tumor Growth and Immune Escape in Pleomorphic Sarcomas | HTML
Frontiers | Genetic Alterations in Gliomas Remodel the Tumor Immune Microenvironment and Impact Immune-Mediated Therapies
IHC staining for ATRX. Diffuse (A), anaplastic astrocytomas (C) and... | Download Scientific Diagram
ESMO17. STUDIU: Determinarea în exces a markerilor tumorali produce anxietate pacienților și determină costuri inutile
Frontiers | Current Opinion on Molecular Characterization for GBM Classification in Guiding Clinical Diagnosis, Prognosis, and Therapy
Glioma Markers - Atlas Antibodies
Tumor-infiltrating lymphocytes predict survival outcomes in patients with cervical cancer treated with concurrent chemoradiotherapy - Gynecologic Oncology
ATRX alteration contributes to tumor growth and immune escape in pleomorphic sarcomas | bioRxiv
A Review of Radiomics and Deep Predictive Modeling in Glioma Characterization - Academic Radiology
ATRX alteration contributes to tumor growth and immune escape in pleomorphic sarcomas | bioRxiv
ATRX driver mutation in a composite malignant pheochromocytoma - Cancer Genetics
Molecular Markers of Gliomas to Predict Treatment and Prognosis: Current State and Future Directions | Exon Publications
PD-L1 expression on immune cells, but not on tumor cells, is a favorable prognostic factor for head and neck cancer patients | Scientific Reports
